Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
Discussion of "Calibrated Bayes, for Statistics in General, and Missing Data in Particular" by R. J. A. Little Discussion of "Calibrated Bayes, for Statistics in General, and Missing Data in ...
The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. JAMA published three perspectives -- two welcoming ...
Marty Makary was appointed commissioner of the Food and Drug Administration (FDA) in 2025. The prominent surgeon, medical researcher, bestselling author, and critic of the medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results